Macro- and micro-influencers of antimicrobial costs…What do stewardship programs need to know?

Area of Science:

• Infectious Diseases
• Health Economics
• Public Health Policy

Background:

• High antimicrobial drug prices create significant barriers to effective infection management.
• Antimicrobial resistance (AMR) is a growing global threat, exacerbated by treatment access issues.
• Disparities in healthcare access are worsened by the prohibitive cost of essential antimicrobials.

Discussion:

• Elevated antimicrobial costs force the use of inferior or more toxic treatments, leading to poorer patient outcomes and extended hospital stays.
• Suboptimal treatment due to cost contributes to increased overall healthcare expenditures.
• The economic burden of antimicrobial treatment access challenges undermines global efforts to control AMR.

Key Insights:

• Antimicrobial cost is a critical factor in managing infections and addressing AMR.
• High prices disproportionately affect vulnerable populations, widening health inequities.
• Effective antimicrobial stewardship is compromised by financial barriers to essential medicines.

Outlook:

• Implementing equitable policies, such as national formularies and cost caps, is vital for universal access to antimicrobials.
• Policy interventions can ensure life-saving treatments are accessible, supporting robust antimicrobial stewardship programs.
• Addressing antimicrobial costs is essential for improving patient outcomes and strengthening global AMR containment strategies.